Radius Health, Inc.
NASDAQ:RDUS
16.4 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2,882.224 | 3,485.815 | 2,758.551 | 1,712.343 | 173.317 | 99.239 | 22.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 2,574.513 | 2,997.745 | 2,305.357 | 1,503.725 | 16.085 | 8.426 | 1.332 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 307.711 | 488.07 | 453.194 | 208.618 | 157.232 | 90.813 | 20.78 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.107 | 0.14 | 0.164 | 0.122 | 0.907 | 0.915 | 0.94 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 0 | 0 | 134.626 | 159.712 | 116.757 | 99.911 | 83.076 | 107.406 | 68.28 | 45.719 | 60.536 | 54.961 | 36.179 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 144.154 | 152.704 | 184.164 | 186.677 | 77.542 | 30.797 | 13.674 | 6.829 | 9.469 | 5.33 | 0.047 | 0.032 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 43.722 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 265.929 | 263.257 | 242.463 | 187.876 | 152.704 | 184.164 | 186.677 | 77.542 | 30.797 | 13.674 | 6.829 | 9.469 | 5.33 | 0.047 | 0.032 | 0 |
Other Expenses
| -5.562 | -0.692 | -0.455 | -0.124 | 0 | 10.801 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 265.929 | 263.257 | 242.463 | 187.876 | 269.461 | 294.876 | 269.753 | 184.948 | 99.077 | 59.393 | 67.365 | 64.43 | 41.509 | 0.047 | 0.032 | 0 |
Operating Income
| -3.925 | 225.906 | 213.729 | 6.854 | -112.229 | -204.063 | -248.973 | -184.948 | -99.077 | -59.393 | -67.365 | -64.43 | -41.509 | -0.047 | -0.032 | 0 |
Operating Income Ratio
| -0.001 | 0.065 | 0.077 | 0.004 | -0.648 | -2.056 | -11.26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| -51.269 | 0.401 | 2.543 | -14.012 | -20.764 | -17.274 | -5.264 | 2.144 | -2.449 | -3.086 | 6.675 | -4.698 | -0.236 | 0 | 0 | 0 |
Income Before Tax
| -28.076 | 216.676 | 207.989 | -1.939 | -132.993 | -221.337 | -254.237 | -182.804 | -101.526 | -62.479 | -60.69 | -69.128 | -14.63 | -0.047 | 0 | 0 |
Income Before Tax Ratio
| -0.01 | 0.062 | 0.075 | -0.001 | -0.767 | -2.23 | -11.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -2.747 | 44.597 | 37.935 | 0.166 | 3.599 | 5.176 | 3.034 | 2.144 | -0.564 | -0.619 | 9.115 | -2.031 | 0.522 | 0 | 0.032 | 0 |
Net Income
| -25.791 | 168.8 | 165.112 | -4.145 | -132.993 | -221.337 | -254.237 | -182.804 | -101.526 | -62.479 | -60.69 | -69.128 | -42.476 | -0.047 | -0.032 | 0 |
Net Income Ratio
| -0.009 | 0.048 | 0.06 | -0.002 | -0.767 | -2.23 | -11.498 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.92 | 6.01 | 5.9 | -0.15 | -2.89 | -4.88 | -5.8 | -4.24 | -2.56 | -3.53 | -7.94 | -7.11 | -169.92 | -0.019 | -0.013 | 0 |
EPS Diluted
| -0.92 | 5.72 | 5.66 | -0.15 | -2.89 | -4.88 | -5.8 | -4.24 | -2.56 | -3.53 | -7.94 | -7.11 | -24.59 | -0.019 | -0.013 | 0 |
EBITDA
| 38.31 | 226.861 | 214.282 | 21.452 | -106.322 | -196.02 | -243.988 | -182.218 | -99.465 | -59.935 | -58.223 | -66.417 | -41.678 | -0.047 | -0.032 | 0 |
EBITDA Ratio
| 0.013 | 0.065 | 0.078 | 0.013 | -0.613 | -1.975 | -11.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |